SLIDE 6 P1 Sep–Oct 2012 • Timothy Van Zandt • Prices & Markets Session 13-Bis • Imperfect competition with entry/exit Page 6
11
Numerical example with free entry
All firms have same fixed cost Number
Total Output Price Output per firm Profit per firm Q = 1500 - 50P || P = 30 - Q/50 1 500 20.00 500 5,000 2 667 16.67 333 2,222 3 750 15.00 250 1,250 4 800 14.00 200 800 5 833 13.33 167 556 6 857 12.86 143 408 7 875 12.50 125 313 8 889 12.22 111 247 9 900 12.00 100 200 10 909 11.82 91 165 11 917 11.67 83 139 12 923 11.54 77 118 13 929 11.43 71 102 14 933 11.33 67 89 15 938 11.25 63 78
FC 350 1000 N∗
6 3
P∗
12.86 15.00
12
Let’s try again, this time using insights from IC+FE
Q: Why do pharmaceutical companies charge so much for AIDS medicine? A: Because they have to recover R&D expenses.
Higher R&D expenses do lead to higher prices, but … Not because any firm takes them into account when setting prices. Instead, because the higher R&D expenses limit entry. The resulting lack of competition is what leads to higher prices.